Jefferies London Healthcare Conference 2023 (Credit: Reynald Castañeda for Endpoints News)
November 16, 2023 06:08 AM EST
People
Pharma

Heard at #Jef­feries23: Al­ny­lam, Bi­cy­cle, In­tel­lia, Nous­com, Rakuten Med­ical ex­ecs fore­cast 2024

Ayisha Sharma

News Reporter

Reynald Castañeda

Deputy Editor

Anna Brown

News Reporter

At this year’s Jef­feries Lon­don Health­care Con­fer­ence, over 3,000 del­e­gates crammed in­to the nar­row hall­ways of the Wal­dorf Hilton. It was like speed dat­ing: Com­pa­nies …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times